Company / Operating Income
Incyte Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$1.5B
FY2025
5-year range
$61.4M / $1.5B
FY2021-FY2025
Trend
+2368.6%
vs FY2024
Sector context
#10 of 204
Health Care
What the data says
Operating Income changed +2369% YoY in FY2025, a notable deviation from the 9-year average annual change of +265%.
Based on SEC 10-K filings.
$1.5B in FY2025 with a 5-year CAGR of +63.6%. Top quartile in the Health Care sector.
Improved from $621M to $1.5B over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +37.8%
- 5-Year CAGR
- +63.6%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 204This company $1.5B Sector average $107.7M
▼
+1306.3% above sector average
Key checks
Key Insights
- 5-year CAGR of +63.6%, indicating consistent growth.
- In FY2025, operating income increased 2368.6% year-over-year.
- Ranks #10 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.7%
- Strong return on equity: 25.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.5B | +2368.6% |
| FY2024 | $61.4M | -90.1% |
| FY2023 | $620.5M | +7.1% |
| FY2022 | $579.4M | -1.1% |
| FY2021 | $585.8M | +353.3% |
| FY2020 | $129.2M | +153.1% |
| FY2019 | -$243.4M | -288.3% |
| FY2018 | $129.2M | +153.1% |
| FY2017 | -$243.4M | -267.9% |
| FY2016 | $145.0M | +186.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026